The largest database of trusted experimental protocols

Cobas taqman mtb test

Manufactured by Roche
Sourced in Switzerland

The Cobas TaqMan MTB test is a qualitative in vitro diagnostic test for the direct detection of Mycobacterium tuberculosis complex DNA from clinical specimens. The test utilizes real-time PCR technology to amplify and detect specific DNA sequences, providing results that aid in the diagnosis of tuberculosis.

Automatically generated - may contain errors

5 protocols using cobas taqman mtb test

1

Diagnosing Pediatric Tuberculosis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Clinical and anthropometric data were recorded. A chest radiograph (CXR), anterioposterior view, was interpreted by 3 independent radiologists. Agreement by 2 radiologists was required to classify a CXR as consistent with TB. A TST was performed by a trained nurse/doctor (2 TU/0.1 mL tuberculin; Span Diagnostics Ltd, Gujarat, India) and read after 48 hours. Peripheral blood (3 mL) was drawn for the QFT (Cellestis/Qiagen, Carnegie, Victoria, Australia) which was performed according to the manufacturer’s instructions.
Gastric aspirates and induced sputa were collected on 2 consecutive days for fluorescent microscopy (Auramine) and culture on solid (Löwenstein-Jensen) and liquid (Mycobacterial Growth Indicator Tube, BD) medium. Positive results were confirmed by Ziehl-Neelsen staining and speciated using the HAIN kit (GenoType MTBC, Ver1, Hain Life Sciences, Germany). Direct PCR (The COBAS TaqMan MTB Test, Roche 2007) was done on all culture-negative specimens in children with CXR consistent with TB. The HIV status was not assessed, but data from a household contact study conducted in the same study area during the period 2010–2012 found a HIV prevalence <1% (TB Trials Study Group, unpublished data).
+ Open protocol
+ Expand
2

Comparative Evaluation of TB Diagnostic Platforms

Check if the same lab product or an alternative is used in the 5 most similar protocols
All compared studies had to be performed with a common CE-IVD certified, commercially available platform. In addition, specimens had to be obtained in a comparable epidemiological setting: the standard used in this work is a low incidence or notification rate of <10 TB cases /100.000 population23 (link). For a better comparability of study results only respiratory specimens were taken into account. A PubMed/NCBI research was performed using the search-terms: “evaluation” and “performance” with each of the chosen platforms’ names: GeneXpert MTB/RIF (Cepheid), ProbeTec ET Mycobacterium tuberculosis complex Direct Test (DTB) (Becton- Dickinson), COBAS Taq-Man MTB Test (Roche, Basel, Switzerland) altogether and separately in every combination. Only publications in English were included.
+ Open protocol
+ Expand
3

Isolating and Culturing Virulent M. tuberculosis

Check if the same lab product or an alternative is used in the 5 most similar protocols
M. tuberculosis were obtained from a clinical virulent strain identified by the Mycobacteriology Laboratory, MacKay Memorial Hospital. Firstly, M. tuberculosis was identified by a MPT64 rapid test, arylsulfatase test, and nitrate reductase assay. The identified strain was further confirmed by a commercial TB-PCR kit (COBAS, Taqman MTB test, Roche). Seed stocks of the collected strain were maintained in small aliquots at -80 °C. The M. tuberculosis used throughout this study was prepared from the seed stocks by culturing on 7H11 agar plate for 3 weeks at 37 °C in 10 % CO2 humidified atmosphere. The culture medium used was a 7H9 broth supplemented with 0.2 % glycerol, 0.05 % Tween-80 and 10 % oleic acid-albumin-dextrose-catalase enrichment (Difco, Becton Dickinson and Company, MD, USA) to an optical density at 600 nm of 0.3 and used as the inoculum.
+ Open protocol
+ Expand
4

Diagnostic Evaluation of Mycobacterial Infections

Check if the same lab product or an alternative is used in the 5 most similar protocols
We performed AFB staining with auramine–rhodamine fluorescent stain and then confirmed with Ziehl–Neelsen staining. We graded the staining results according to the American Thoracic Society/Centers for Disease Control and Prevention guidelines.[9 (link)] Then, specimens classified with AFB smear staining results in Grades 1–4 were defined as smear-positive. All clinical specimens were cultured on solid and liquid media for 6 weeks. We inoculated the decontaminated samples into a mycobacterium growth indicator tube (MGIT 960 system; Becton Dickinson, Sparks, MD) and inoculated onto 3% Ogawa agar (Shenyang, Seoul, Korea). All positive cultures were examined by AFB smear to confirm the presence of AFB and to rule out contamination. The Cobas TaqMan MTB test (Cobas MTB test) (Roche Diagnostics, Basel, Switzerland) is a real-time PCR method for analyzing sputum and pleural effusion samples.[9 (link)]
+ Open protocol
+ Expand
5

Mycobacterial Detection and Identification

Check if the same lab product or an alternative is used in the 5 most similar protocols
AFB staining was performed with an auramine-rhodamine fluorescent stain, followed by confirmation with Ziehl-Neelsen staining. Staining results were graded according to the American Thoracic Society/Centers for Disease Control and Prevention guidelines [17 (link)]. Specimens in which the AFB smear results were categorized as grades 1 to 4 were defined as smear-positive. All clinical specimens were cultured on both solid and liquid medium for 6 weeks. To this end, decontaminated samples were inoculated into a mycobacterial growth indicator tube (MGIT 960 system; Becton Dickinson, Sparks, MD) and also onto 3% Ogawa agar (Shinyang, Seoul, Korea). All positive cultures were subjected to an AFB smear to confirm the presence of AFB and to exclude contamination. The Cobas TaqMan MTB test (Cobas MTB test) (Roche Diagnostics, Basel, Switzerland), which is a real-time PCR assay, was used to analyze sputum and pleural effusion samples [18 (link)].
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!